Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 12

Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam For Scalp Psoriasis

Authors Anderko M, Navarro Triviño FJ, Sharples CL

Received 27 June 2019

Accepted for publication 4 September 2019

Published 17 September 2019 Volume 2019:12 Pages 699—705

DOI https://doi.org/10.2147/CCID.S221078

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Jeffrey Weinberg


Marian Anderko,1 Francisco José Navarro Triviño,2 Charlotte L Sharples3

1Dermatologikum, Hamburg 20354, Germany; 2Dermatology and Venereology, Hospital Universitario San Cecilio, Granada 18016, Spain; 3LEO Pharma UK, Hurley, Berks, UK

Correspondence: Marian Anderko
Dermatologikum, Stephansplatz 5, Hamburg 20354, Germany
Tel +49 40 3510750
Fax +49 40 35107510
Email anderkomarian@gmail.com

Abstract: This article presents real-world experience of the effectiveness of calcipotriol (50 μg/g)/betamethasone dipropionate (0.5 mg/g) (Cal/BD) aerosol foam formulation in three cases of scalp psoriasis, and briefly reviews the literature relating to Cal/BD topical therapy in adults with scalp psoriasis. Patients had long histories of scalp psoriasis and reported negative impacts on their lives (e.g. clothing choices, psychological well-being, employment status). Previous treatments had provided inadequate or only temporary relief. Cal/BD aerosol foam relieved itching in the first few days and was associated with visible improvement of flaky patches on the scalp at the end of the recommended 4-week treatment period. Controlled clinical trials in patients with scalp psoriasis are rare. There have been several trials in adults with scalp psoriasis involving Cal/BD gel or suspension scalp formulations, which have proven more effective and well tolerated compared with the individual components or vehicle alone. The Cal/BD aerosol formulation has enhanced skin penetration and higher bioavailability compared with the older formulations; studies show improved efficacy with Cal/BD aerosol foam, compared with older formulations, in patients with plaque psoriasis. The present cases confirm the benefits of Cal/BD aerosol foam in adults with scalp psoriasis, treated in real-world settings.

Keywords: aerosol, betamethasone dipropionate, calcipotriol, psoriasis, scalp psoriasis

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]